EASTERN COOPERATIVE ONCOLOGY GROUP

罗切斯特大学癌症中心(URCC)是一个健康和 以多医院联盟形式组织的研究机构 涉及五家提供全方位服务的社区医院。市建局是 致力于临床和基础实验室研究，病人护理， 和教育。五家医院中每一家的所有执业肿瘤学家 医院必须并确实同时举行至少两次初选 预约--一个在癌症中心，一个在大学 部门-并受两个部门的政策和程序约束 中心和部门。表演网站还包括我们的 加拿大魁北克市的加拿大外展讽刺作家和一个财团 纽约州北部的CCOP工厂。 我们非常适合参加东部合作社 肿瘤学小组治疗试验、癌症控制研究和其他 科学研究活动。继续成为会员将使 美国将把前景看好的临床研究的好处带到 癌症社区，加快癌症治疗的进展， 通过快速数据收集提供信息传播 和出版物，并提高护理和治疗水平 希望提高中国人的生存时间和生活质量 我们的癌症患者。来自ECOG研究的数据和信息 项目在区域、国家和国际上展示。 罗切斯特经社理事会调查人员的会议和会议。 对这个项目来说很重要的是，癌症中心的调查人员 和工作人员提供了实验室研究之间的强大联系 概念，如化疗和辐射增敏剂以及 保护剂，IL-2/LAK细胞研究，化学预防研究，照片- 动力疗法、肿瘤细胞疫苗和淋巴因子研究。 市建局对癌症有长期的兴趣和经验。 控制研究，并将为这一扩大的领域提供专业知识 在经社理事会内部进行研究。关键人员为主席或 在许多ECOG模式的指导委员会任职，疾病 导向型和行政型委员会。 市建中心是为指湖地区提供服务的唯一癌症机构 卫生区面积为120万人。

The University of Rochester Cancer Center (URCC) is a health and research institute organized as a multihospital consortium involving five full-service community hospitals. The URCC is committed to clinical and basic laboratory research, patient care, and education. All practicing oncologists in each of the five hospitals must, and do, hold at least two simultaneous primary appointments - one in the Cancer Center and one in a University department - and are subject to the policies and procedures of both the Center and the department. Performance sites also include our Canadian outreach satillite in Quebec City, Canada and a consortium CCOP facility in upstate NY. We are ideally suited to participate in the Eastern Cooperative Oncology Group treatment trials, cancer control studies, and other scientific research activities. Continued membership will enable us to bring the benefits of promising clinical investigations to the cancer community, accelerate the advances in cancer therapy, provide dissemination of information through rapid data collection and publications, and to improve the level of care and treatment to hopefully enhance the length of survival and quality of life in our cancer patients. Data and information from ECOG research projects are presented at regional, national and international meetings and conferences by the Rochester ECOG investigators. Important to this program is that the Cancer Center investigators and staff provide a strong link between laboratory research concepts, such as chemotherapy and radiation sensitizers and protectors, IL-2/LAK cell studies, chemoprevention studies, photo- dynamic therapy, tumor cell vaccine and lymphokine research. The URCC has a longstanding interest and experience in cancer control studies and will provide expertise to this expanded area of research within the ECOG. Key personnel are chairpersons or serve on steering committees of many of the ECOG modality, disease oriented and administrative committees. The URCC is the only cancer facility serving the Finger Lakes Health Region area, with a population of 1.2 million people.